RxDoctor Payments Data

Madhusudhan Yakkanti, MD

Orthopaedic Surgery · Louisville, KYNPI 1740337930

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $27,750 of the $38,917 with a category attached, or 71.3%. Encore Medical, LP accounts for 71.3% of it on its own, with 25 other manufacturers making up the rest.

$38,917in general payments, 2019–2025

Across 116 payments — averaging $335.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$28K
  • Stryker$4K
  • Depuy Synthes Products, Inc.$4K
  • Smith+Nephew$706
  • Zimmer Biomet$550
  • Johnson & Johnson$430
  • plus $2K from 20 others
$321,459in research payments, 2019–2025

Across 41 payments — averaging $7840.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$321K

What the payments were for

  • Royalty or licence$27,75071%
  • Consulting fees$3,5109%
  • Travel & lodging$8112%
  • Food & beverage$6,19216%
  • Education$6532%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,917 in reported general payments places this provider in the 85th percentile of 322 orthopaedic surgery providers in Kentucky.

See all orthopaedic surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$368,679
Medicare patients
556
Services billed
5,392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen221$1,524
Ondansetron OdtOndansetron67$944
Diclofenac Sodium32$438
Meloxicam149$406
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$367
Ondansetron Hcl51$321
Gabapentin47$296
Cyclobenzaprine Hcl18$142
Amoxicillin64$136
Tramadol Hcl22$85
Ibuprofen13$44

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →